Results 191 to 200 of about 29,068 (273)

Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example

open access: yesClinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Early clinical development of anticancer drugs traditionally focused on exploring candidate treatments in patients. For instance, due to their cytotoxic action, administration of chemotherapies to healthy volunteers (HVs) for evaluation of their pharmacokinetic profiles was not considered feasible nor ethical from a safety and tolerability ...
Aernout D. van Haarst   +5 more
wiley   +1 more source

Project Newsletter, M12

open access: yes
Release of the second EFFECTIVE ...
openaire   +1 more source

Healthcare Professionals' Perceptions of Artificial Intelligence in Healthcare—A Systematic Review of Qualitative Studies

open access: yesJournal of Advanced Nursing, Volume 82, Issue 9, Page 8304-8343, September 2026.
ABSTRACT Aim To identify the experiences and perceptions of healthcare professionals on artificial intelligence in healthcare. Design Systematic literature review of qualitative studies and meta‐aggregation. Data Sources CINAHL, PubMed, Scopus, Medic and ProQuest were systematically searched on December 9, 2024. Results Twenty‐six studies were included
Huotari Sini   +6 more
wiley   +1 more source

Annual conference (M12)

open access: yes
The first annual conference is organised and info on time agenda participants and results ...
openaire   +1 more source

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1490-1501, September 2026.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

Everolimus-based immunosuppression induces alloreactive regulatory T cell expansion combined with loss of alloreactive effector T cells. [PDF]

open access: yesFront Immunol
Litjens NHR   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy